Half-year report · HY

Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥18.9bn2025-10-01 → 2026-03-31Cons.Net sales
Revenue¥34.4bn2024-10-01 → 2025-09-30Cons.Net sales (5-year summary)
Revenue¥17.8bn2024-10-01 → 2025-03-31Cons.Net sales
Operating income¥530m2025-10-01 → 2026-03-31Cons.Operating income
Operating income¥325m2024-10-01 → 2025-03-31Cons.Operating income
Ordinary income¥565m2025-10-01 → 2026-03-31Cons.Ordinary income
Ordinary income¥595m2024-10-01 → 2025-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥355m2024-10-01 → 2025-03-31Cons.Ordinary income
Profit before tax¥576m2025-10-01 → 2026-03-31Cons.Income before income taxes
Profit before tax¥400m2024-10-01 → 2025-03-31Cons.Income before income taxes
Net income (owners)¥396m2025-10-01 → 2026-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥429m2024-10-01 → 2025-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥269m2024-10-01 → 2025-03-31Cons.Profit loss attributable to owners of parent
Net income¥400m2025-10-01 → 2026-03-31Cons.Profit loss
Net income¥273m2024-10-01 → 2025-03-31Cons.Profit loss
Total assets¥20.4bnat 2026-03-31Cons.Assets
Total assets¥18.4bnat 2025-09-30Cons.Assets
Total assets¥18.5bnat 2025-03-31Cons.Total assets (5-year summary)
Total liabilities¥11.8bnat 2026-03-31Cons.Liabilities
Total liabilities¥10.4bnat 2025-09-30Cons.Liabilities
Net assets / equity¥8.5bnat 2026-03-31Cons.Net assets
Net assets / equity¥8.0bnat 2025-09-30Cons.Net assets
Net assets / equity¥7.7bnat 2025-03-31Cons.Net assets (5-year summary)
Cash and deposits¥3.7bnat 2026-03-31Cons.Cash and deposits
Cash and deposits¥925mat 2025-09-30Cons.Cash and deposits
Cash & equivalents¥3.7bnat 2026-03-31Cons.Cash and cash equivalents
Cash & equivalents¥911mat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.5bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥745mat 2024-09-30vCons.Cash and cash equivalents
Operating cash flow¥2.9bn2025-10-01 → 2026-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥150m2024-10-01 → 2025-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥674m2024-10-01 → 2025-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥33m2025-10-01 → 2026-03-31Cons.Net cash provided by used in investment activities
Investing cash flow¥19m2024-10-01 → 2025-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥62m2024-10-01 → 2025-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥53m2025-10-01 → 2026-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥3m2024-10-01 → 2025-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥6m2024-10-01 → 2025-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥439.522025-10-01 → 2026-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥475.932024-10-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥298.42024-10-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio41.5%at 2026-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio43.0%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio40.9%at 2025-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Academia Life Science Sales Groupreportable segmentrevenue2025-10-01 → 2026-03-31¥1.3bn
Academia Life Science Sales Groupreportable segmentrevenue external2025-10-01 → 2026-03-31¥1.3bn
Industry Sales Groupreportable segmentrevenue2025-10-01 → 2026-03-31¥9.6bn
Industry Sales Groupreportable segmentrevenue external2025-10-01 → 2026-03-31¥9.6bn
Medical Sales Groupreportable segmentrevenue2025-10-01 → 2026-03-31¥8.0bn
Medical Sales Groupreportable segmentrevenue external2025-10-01 → 2026-03-31¥8.0bn
—segment totalrevenue2025-10-01 → 2026-03-31¥18.9bn
—segment totalrevenue external2025-10-01 → 2026-03-31¥18.9bn
Academia Life Science Sales Groupreportable segmentrevenue2024-10-01 → 2025-03-31¥1.5bn
Academia Life Science Sales Groupreportable segmentrevenue external2024-10-01 → 2025-03-31¥1.5bn
Industry Sales Groupreportable segmentrevenue2024-10-01 → 2025-03-31¥9.1bn
Industry Sales Groupreportable segmentrevenue external2024-10-01 → 2025-03-31¥9.1bn
Medical Sales Groupreportable segmentrevenue2024-10-01 → 2025-03-31¥7.2bn
Medical Sales Groupreportable segmentrevenue external2024-10-01 → 2025-03-31¥7.2bn
—segment totalrevenue2024-10-01 → 2025-03-31¥17.8bn
—segment totalrevenue external2024-10-01 → 2025-03-31¥17.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 510
ItemContextValueUnit
Allowance for doubtful accounts caPrior1YearInstant-4804000JPY
Allowance for doubtful accounts caInterimInstant-3583000JPY
Current assetsPrior1YearInstant12825935000JPY
Current assetsInterimInstant14421275000JPY
Buildings and structures netPrior1YearInstant534823000JPY
Buildings and structures netInterimInstant540615000JPY
LandPrior1YearInstant1450053000JPY
LandInterimInstant1450053000JPY
Lease assets net ppePrior1YearInstant123769000JPY
Lease assets net ppeInterimInstant143304000JPY
Other net ppePrior1YearInstant336452000JPY
Other net ppeInterimInstant336268000JPY
Property plant and equipmentPrior1YearInstant2445098000JPY
Property plant and equipmentInterimInstant2470241000JPY
Lease assets iaPrior1YearInstant11741000JPY
Lease assets iaInterimInstant9697000JPY
SoftwarePrior1YearInstant242786000JPY
SoftwareInterimInstant213824000JPY
Intangible assetsPrior1YearInstant254528000JPY
Intangible assetsInterimInstant223521000JPY
Investment securitiesPrior1YearInstant2003550000JPY
Investment securitiesInterimInstant2363204000JPY
Lease investment assets ioaPrior1YearInstant232386000JPY
Lease investment assets ioaInterimInstant213267000JPY
Net defined benefit assetPrior1YearInstant81077000JPY
Net defined benefit assetInterimInstant82016000JPY
Other ioaPrior1YearInstant601792000JPY
Other ioaInterimInstant600756000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-21541000JPY
Allowance for doubtful accounts ioa by groupInterimInstant-21780000JPY
Investments and other assetsPrior1YearInstant2897265000JPY
Investments and other assetsInterimInstant3237464000JPY
Noncurrent assetsPrior1YearInstant5596892000JPY
Noncurrent assetsInterimInstant5931227000JPY
AssetsPrior1YearInstant18422827000JPY
AssetsInterimInstant20352502000JPY
Notes and accounts payable tradePrior1YearInstant8012854000JPY
Notes and accounts payable tradeInterimInstant8906397000JPY
Electronically recorded obligations operating clPrior1YearInstant460997000JPY
Electronically recorded obligations operating clInterimInstant899314000JPY
Short term loans payablePrior1YearInstant312000000JPY
Short term loans payableInterimInstant409000000JPY
Current portion of long term loans payablePrior1YearInstant27530000JPY
Current portion of long term loans payableInterimInstant20390000JPY
Lease obligations clPrior1YearInstant122449000JPY
Lease obligations clInterimInstant123102000JPY
Accounts payable otherPrior1YearInstant87676000JPY
Accounts payable otherInterimInstant38298000JPY
Income taxes payablePrior1YearInstant173932000JPY
Income taxes payableInterimInstant144684000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-09-30pass
balance sheet identityconsolidated 2026-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net assetsconsolidated 2026-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-10-01/2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2025-10-01/2026-03-31pass
statement vs summary · operating cash flowconsolidated 2024-10-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2025-10-01/2026-03-31pass
statement vs summary · revenueconsolidated 2024-10-01/2025-03-31pass
statement vs summary · revenueconsolidated 2025-10-01/2026-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass
statement vs summary · total assetsconsolidated 2026-03-31pass